ENDRA Life Sciences (NDRA) Cost of Revenue: 2016-2021
Historic Cost of Revenue for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to $382,113.
- ENDRA Life Sciences' Cost of Revenue rose 98.58% to $382,113 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.1 million, marking a year-over-year increase of 84.81%. This contributed to the annual value of $571,040 for FY2024, which is 30.41% down from last year.
- According to the latest figures from Q4 2021, ENDRA Life Sciences' Cost of Revenue is $382,113, which was up 38.67% from $275,565 recorded in Q3 2021.
- ENDRA Life Sciences' Cost of Revenue's 5-year high stood at $382,113 during Q4 2021, with a 5-year trough of $1,124 in Q1 2017.
- Its 3-year average for Cost of Revenue is $172,475, with a median of $150,343 in 2020.
- In the last 5 years, ENDRA Life Sciences' Cost of Revenue tumbled by 74.64% in 2017 and then skyrocketed by 9,435.32% in 2018.
- Quarterly analysis of 5 years shows ENDRA Life Sciences' Cost of Revenue stood at $3,085 in 2017, then surged by 1,259.09% to $41,928 in 2018, then surged by 298.47% to $167,070 in 2019, then increased by 15.18% to $192,424 in 2020, then surged by 98.58% to $382,113 in 2021.
- Its last three reported values are $382,113 in Q4 2021, $275,565 for Q3 2021, and $256,763 during Q2 2021.